Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ, Ｉｎｃ．
ＤｅｌｔａーＦｌｙ Ｐｈａｒｍａ株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4598
FY2025 · 2026-03-31
| Gross margin | — |
| Operating margin | — |
| Net margin | — |
| Return on equity | — |
| Return on assets | -659.2% |
| Revenue growth (YoY) | — |
| EPS (basic) | ¥-140.45 |
| EPS growth (YoY) | — |
| Current ratio | 0.98x |
| Equity ratio | 12.6% |
| Book value / share | ¥2.35 |
| Free cash flow | — |